PDF Solutions Announces the Release of Exensio(TM)-Test

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
PDF Solutions Announces the Release of Exensio(TM)-Test Augmenting Its Big Data Solution for IC Manufacturing

SAN JOSE, CA--(Marketwired - April 26, 2015) - The leading provider of yield improvement technologies and services for the integrated circuit (IC) process life cycle announced today the release of Exensio(TM)-Test software for semiconductor companies. PDF Solutions (NASDAQ: PDFS) is well known for its expertise in process equipment control with the Exensio Platform, comprising the Exensio(TM)-Yield and Exensio(TM)-Control modules for yield improvement as well as fault detection and classification. Based on customer feedback, PDF Solutions has now expanded the platform to address critical areas of test, packaging and assembly with its new Exensio-Test offering. This module combines technology gained through the acquisition of key semiconductor software assets from Salland Engineering entities with the Big Data capabilities of PDF's Exensio Platform. This new module provides test floor operation, adaptive test and analysis technology that produces diagnostic and predictive information during test, assembly and packaging operations. This information is critical to optimizing customers' test operations, productivity and yields.

Exensio-Test, now deployed and available worldwide, enables semiconductor manufacturers to improve the efficiency and quality of their testing, as well as experience these additional benefits:

- Significantly reduced test times through the implementation of real-time adaptive test algorithms. This reduction is required for advanced products and processes with stringent PPM (parts-per-million) defectivity requirements.

- Reduced test time through optimization of test probe setup selection and simultaneous tester/prober recipe optimization.

- Increased test productivity and insight into test floor efficiency across a variety of subcontractor and in-house test facilities with real-time alarms and actions.

- Linking of manufacturing data to root causes seen in wafer sort and final test, through utilization of advanced analysis, data mining and modeling features, as well as implementation of predictive alarms.

- Co-optimization of overall equipment effectiveness (OEE), UPM, productivity and yield, when paired with PDF Solutions' scribe CV(R) technologies. This enables customers to optimize adaptive test.

As part of the development of Exensio-Test, PDF Solutions acquired key semiconductor software assets from Salland Engineering entities. Salland Engineering's solutions were successfully implemented for test, packaging and assembly management on a worldwide basis. As part of the asset purchase, PDF Solutions acquired the following products from Salland: SE Probe and related modules, Optimizer, MapWarehouse (MWH), SE Dana, Quest, Skeleton, CM-FT, CCT, SwifTest, TestScape, and TestVision. PDF Solutions continues to license and support these products as acquired from Salland, and will further develop and integrate them into the Exensio-Test module. PDF Solutions has already secured multi-year license and support agreements with many of Salland's former customers for the continued use of these products.

"We're happy to see that PDF has acquired these assets of Salland and excited to see integration of Salland's testing technology to round out the Exensio platform and provide a seamless link between our manufacturing data and the data we see at our subcontractors and test facilities," said Bob Lima, Director of Assembly and Test Operations at Peregrine Semiconductor. "We look forward to leveraging the entire Exensio platform with the Exensio-Yield and Exensio-Control modules, to optimize our chip yields and realize its direct positive impact on our profitability."

"PDF Solutions is currently providing customers unified access to process tool-level control, yield, and characterization data through our integrated FDC and YMS capabilities in Exensio," said Said Akar, General Manager at PDF Solutions. "However, we also want to provide state-of-the art testing at the production level. Now with the Salland technology we acquired, our fabless and IDM customers can leverage this information to significantly improve their test productivity, reach higher production yields, lower PPM and achieve a faster time-to-market."

Exensio-Test increases OEE of test cells through optimization of tester configurations, management of tester data, implementation of adaptive test algorithms, as well as other test floor management operations. This high level of testing is critical in many of today's electronics products which have stringent PPM defectivity requirements. Exensio-Test also has advanced adaptive test capabilities and is able to simultaneously maximize OEE and UPM (units tested per hour).

Forward-Looking Statements

The statements in this press release regarding the expected performance and capabilities of PDF Solutions products and services and the statements regarding continued adoption by customers are forward looking and are subject to events and circumstances of the future. Actual results could differ materially from those expressed in these forward-looking statements. Risks and uncertainties that could cause results to differ materially include risks associated with continued development, support, and market acceptance, and other risks set forth in PDF Solutions' periodic public filings with the Securities and Exchange Commission, including, without limitation, its Annual Report on Form 10-K, most recently filed on March 3, 2015, for the year ended December 31, 2014, other Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, most recently filed for the quarter ended September 30, 2014, and Current Reports on Form 8-K and amendments to such reports. The forward-looking statements made in this press release are made as of the date hereof, and PDF Solutions does not assume any obligation to update such statements or the reasons why actual results could differ materially from those projected in such statements.

About PDF Solutions

PDF Solutions, Inc. (NASDAQ: PDFS) is the leading provider of yield improvement technologies and services for the IC manufacturing process life cycle. PDF Solutions offers solutions that are designed to enable clients to lower costs of IC design and manufacture, enhance time to market, and improve profitability by addressing design and manufacturing interactions from product design to initial process ramps to mature manufacturing operations. PDF Solutions' Characterization Vehicle(R) (CV(R)) electrical test chip infrastructure provides the core modeling capabilities, and is used by more leading manufacturers than any other test chips in the industry. Proprietary Template(TM) layout patterns provide optimum area, performance, and manufacturability for designing IC products. Exensio(TM)-Yield provides world-class variability control in manufacturing by leveraging PDF Solutions' industry-leading yield management technology and fault detection and classification (FDC) with Exensio(TM)-Control software. Exensio(TM)-Test leverages integration and analysis technology that produces diagnostic and predictive information that can be used to further optimize semiconductor yields. Headquartered in San Jose, Calif., PDF Solutions operates worldwide with additional offices in Canada, China, France, Germany, Italy, Japan, Korea, and Taiwan. For the Company's latest news and information, visit http://www.pdf.com/ .

Characterization Vehicle, CV, PDF Solutions, and the PDF Solutions logo are registered trademarks of PDF Solutions, Inc. or its subsidiaries. Exensio, Template and YieldAware are trademarks of PDF Solutions, Inc. or its subsidiaries.

Gregory Walker Chief Financial Officer Tel: (408) 938-6457 Email: gregory.walker@pdf.com Ken Harris Director of Marketing Tel: (408) 938-6473 Email: ken.harris@pdf.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 24

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 19

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 19

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 21

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 14

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

National Power Mobilizes Storm Response Teams for Hurricane

Updated Category News Views 119

National Power's Preparedness for Hurricane Milton As Hurricane Milton approaches, National Power has actively mobilized its dedicated teams to ensure mission-critical operations are not disrupted. With a strong focus on readiness, the company is prepared to deliver essential power and infrastructure support to vital services such as broadband and emergency facilities...

Continue Reading
Edible Garden Reports Significant Revenue Growth in CPG Sector

Updated Category News Views 138

Edible Garden Achieves 9% Revenue Growth Edible Garden AG Incorporated (NASDAQ: EDBL) has reported an encouraging 9% increase in revenue, marking a significant milestone for the company in the competitive consumer packaged goods (CPG) sector. The growth comes as Edible Garden diversifies its product offerings and expands its retail partnerships, positioning itself firmly...

Continue Reading
Sapiens International Announces Impressive Dividend Payouts

Updated Category News Views 304

Sapiens International Declares Substantial Cash Dividend Sapiens International Corporation N.V. (NASDAQ: SPNS), a distinguished leader in providing software solutions for the insurance industry, has unveiled a notable cash dividend distribution following their financial achievements. The board of directors has sanctioned a cash dividend of $0.30 per share, culminating in...

Continue Reading
Cybernet’s G22 Medical PC Revolutionizes Endoscopy at DDW 2025

Updated Category News Views 253

Cybernet’s Groundbreaking Medical Panel PC at DDW 2025 During the recent Digestive Disease Week (DDW) 2025 conference, the spotlight was on revolutionary advancements in endoscopic technology. A significant highlight was the display of the Cybermed G22, a state-of-the-art 22-inch medical panel PC. This cutting-edge device is integral to Fujifilm's next-generation...

Continue Reading
CVS Health's Strategic Moves Boost Medicare Margins and Market Share

Updated Category News Views 96

CVS Health's Strategic Upsurge in the Pharmacy Sector CVS Health Inc (NYSE: CVS) has recently come under the positive spotlight as Barclays improves its outlook on the company. The upgrade stems from more favorable predictions concerning Pharmacy & Consumer Wellness (PCW) estimates. Interestingly, despite facing macroeconomic challenges affecting the retail pharmacy...

Continue Reading